world
popul
risk
infect
dengu
viru
denv
constitut
seriou
threat
public
health
antivir
therapi
avail
potenti
lethal
diseas
efficaci
approv
vaccin
optim
safeti
recent
question
order
develop
better
vaccin
base
attenu
andor
chimer
virus
one
must
consid
human
immun
system
engag
denv
infect
activ
innat
immun
detect
virus
cellular
sensor
first
line
defenc
pathogen
trigger
cascad
event
establish
antivir
state
cell
level
lead
global
immunolog
respons
howev
denv
evolv
interfer
innat
immun
signal
multipl
level
henc
dampen
antivir
respons
favour
viral
replic
dissemin
review
elabor
interplay
denv
innat
immun
system
special
focu
given
viral
countermeasur
mechan
report
last
decad
taken
consider
vaccin
develop
vaccin
serotyp
one
given
restrict
geograph
area
unmet
medic
need
regard
strategi
dengu
incid
diseas
expect
geograph
expand
futur
consid
arthropod
vector
colon
northern
european
american
territori
temper
climat
denv
infect
character
mix
clinic
present
rang
asymptomat
diseas
mild
febril
prodrom
way
sever
hemorrhag
fever
shock
syndrom
infect
individu
asymptomat
transmit
denv
aed
mosquito
blood
meal
make
difficult
precis
estim
actual
size
reservoir
given
time
denv
infect
sever
classifi
accord
world
health
organ
guidelin
dengu
without
warn
sign
dengu
fever
regroup
atrisk
individu
fever
least
two
follow
sign
symptom
nauseavomit
rash
headach
eye
pain
muscl
ach
joint
pain
leukopenia
posit
tourniquet
test
dengu
warn
sign
sever
infect
dengu
hemorrhag
fever
includ
addit
previou
sign
symptom
abdomin
pain
persist
vomit
ascit
pleural
effus
mucos
bleed
lethargi
restless
hepatomegali
increas
hematocrit
pair
rapid
decreas
platelet
count
lastli
sever
dengu
dengu
shock
occur
infect
lead
sever
plasma
leakag
massiv
bleed
multipl
organ
failur
therapeut
arsen
denv
infect
fairli
limit
consist
support
care
intraven
fluid
therapi
hostpathogen
interact
point
view
interest
note
major
denvinfect
individu
viremia
control
innat
adapt
immun
system
within
three
seven
day
independ
clinic
manifest
howev
case
infect
properli
handl
symptom
aggrav
higher
peak
viral
titr
seem
predict
diseas
sever
pathophysiolog
behind
sever
dengu
fulli
understood
accept
dengu
hemorrhag
fever
sever
dengu
result
cytokinemedi
patholog
cytokin
storm
occur
unbalanc
product
variou
solubl
shortliv
immun
factor
vegfa
produc
immun
cell
denv
envelop
positivestrand
rna
viru
belong
flaviviru
genu
within
flavivirida
famili
flavivirus
also
includ
genet
relat
andor
medic
relev
arthropodborn
pathogen
yellow
fever
viru
yfv
zika
viru
zikv
west
nile
viru
wnv
japanes
enceph
viru
jev
envelop
virion
constitut
prmm
precursor
membranemembran
e
envelop
structur
protein
surfac
c
nucleocapsid
protein
surround
kilobaselong
nonseg
viral
rna
genom
vrna
follow
viru
entri
target
cell
vrna
translat
one
polyprotein
subsequ
process
host
viral
proteas
gener
structur
protein
c
prm
e
seven
nonstructur
ns
protein
ns
protein
respons
vrna
replic
occur
exclus
cytoplasm
infect
cell
involv
specif
enzymat
activ
sever
ns
protein
rnadepend
rna
polymeras
respons
vrna
synthesi
possess
methyltransferas
activ
absolut
requir
vrna
cap
omethyl
process
denv
polyprotein
involv
serin
proteas
activ
complex
also
essenti
vrna
synthesi
cap
helicas
ntpase
triphosphatas
activ
assembl
virion
bud
endoplasm
reticulum
er
taken
charg
cellular
secret
machineri
golgi
apparatu
undergo
final
round
furinmedi
matur
acquir
infect
releas
via
exocytosi
order
creat
cytoplasm
environ
sustain
optim
life
cycl
denv
much
like
flavivirus
induc
within
infect
cell
biogenesi
specif
vaccin
membran
replic
organel
replic
factori
rf
uniqu
morpholog
rf
form
alter
curvatur
composit
cellular
endomembran
character
erderiv
ultrastructur
includ
vesicl
packet
vp
result
membran
invagin
contain
vrna
replic
compon
convolut
membran
cm
enrich
exact
role
remain
poorli
defin
viru
bag
contain
immatur
virion
organ
regular
array
addit
denv
also
manipul
architectur
organel
mitochondria
peroxisom
modul
specif
cellular
function
includ
innat
immun
favour
replic
see
denv
genet
simpl
viral
protein
express
life
cycl
reli
highli
coordin
machineri
offer
variou
point
intervent
research
interest
follow
entri
viru
insid
cell
rapidli
sens
foreign
intrud
cell
surveil
machineri
trigger
innat
immun
strikingli
respons
defenc
mechan
denv
evolv
effici
hide
mask
foreign
molecular
signatur
henc
avoid
establish
antivir
environ
detriment
replic
addit
cloakanddagg
oper
mani
viral
protein
abl
directli
hit
host
antivir
machineri
shutdown
innat
immun
signal
thu
antivir
immun
denv
life
cycl
dynam
interconnect
event
balanc
one
hand
viru
tri
hijack
function
cellular
machineri
benefit
hand
host
factor
tri
control
viral
infect
minim
damag
cell
homeostasi
review
elabor
interplay
denv
innat
immun
precis
bring
focu
denv
detect
insid
infect
cell
well
hide
avoid
detect
better
understand
denv
circumv
andor
attenu
innat
immun
provid
critic
inform
ration
vaccin
develop
dengu
neglect
tropic
diseas
caus
dengu
viru
denv
transmit
human
aed
aegypti
aed
albopictu
mosquito
recent
year
becom
public
health
concern
given
global
incid
dramat
increas
last
year
effect
antivir
therapi
current
avail
dengu
vaccin
develop
sanofi
pasteur
dengvaxia
recent
approv
countri
around
globe
howev
efficaci
vaccin
optim
denv
serotyp
safeti
serious
question
especi
seroneg
individu
epidemiolog
model
estim
million
billion
peopl
live
endem
epidem
area
contract
diseas
year
make
preval
arboviru
infect
million
infect
individu
per
year
develop
symptomat
dengu
fever
result
thousand
fatal
million
disabilityadjust
life
year
dali
increas
diseas
burden
evenli
distribut
across
globe
latin
america
caribbean
end
sinc
increas
denguerel
dali
global
averag
southeast
asia
account
dali
might
due
simultan
occurr
multipl
factor
lowtomiddl
incom
emerg
countri
affect
complex
balanc
denv
transmiss
dynam
lead
rapid
endemicepidem
cycl
instanc
includ
optim
climat
aed
life
cycl
rapid
increas
popul
densiti
urban
centr
concomit
circul
denv
induc
format
mav
aggreg
serv
immun
signalosom
activ
phosphoryl
transcript
factor
turn
transcript
factor
transloc
nucleu
elicit
transactiv
type
ifn
produc
type
ifn
secret
extracellular
space
activ
paracrin
autocrin
fashion
jakstat
pathway
lead
amplif
antivir
respons
via
activ
transcript
factor
complex
known
infect
also
lead
mitochondri
stress
releas
mtdna
cytosol
mtdna
recogn
cga
activ
sting
lead
activ
ifn
product
denv
develop
variou
countermeasur
evad
andor
engag
rlr
cgasst
pathway
hinder
innat
immun
signal
evas
mechan
includ
posttranscript
modif
vrna
inhibit
hinder
rigi
activ
mav
aggreg
alter
endomembran
architectur
disrupt
mav
signalosom
inhibit
ikbk
kinas
activ
prevent
activ
transcript
factor
like
disrupt
cgasst
signal
dampen
complex
activ
requir
late
innat
antivir
respons
rigilik
receptor
rlr
pathway
classic
studi
role
detect
viral
ribonucl
acid
involv
retino
acidinduc
gene
rigi
melanoma
differentiationassoci
protein
laboratori
genet
physiolog
cytosol
sensor
infect
ubiquit
express
abl
sens
specif
viral
rna
moieti
short
uncap
triphosphoryl
singlestrand
ss
rna
short
doublestrand
ds
rna
uarich
region
viral
rna
long
dsrna
upon
bind
vrna
rigi
activ
transloc
surfac
mitochondria
interact
adaptor
protein
mitochondri
antiviralsignal
protein
mav
via
respect
caspas
activ
recruit
domain
card
figur
upper
panel
protein
induc
format
mav
aggreg
serv
immun
signalosom
activ
phosphoryl
transcript
factor
turn
transcript
factor
transloc
nucleu
elicit
transactiv
type
ifn
produc
type
ifn
secret
extracellular
space
activ
paracrin
autocrin
fashion
jakstat
pathway
lead
amplif
antivir
respons
via
activ
transcript
factor
complex
known
infect
also
lead
mitochondri
stress
releas
mtdna
cytosol
mtdna
recogn
cga
activ
sting
lead
activ
ifn
product
denv
develop
variou
countermeasur
evad
andor
engag
rlr
cgasst
pathway
hinder
innat
immun
signal
evas
mechan
includ
posttranscript
modif
vrna
inhibit
hinder
rigi
activ
mav
aggreg
alter
endomembran
architectur
disrupt
mav
signalosom
inhibit
ikbk
kinas
activ
prevent
activ
transcript
factor
like
disrupt
cgasst
signal
dampen
complex
activ
requir
late
innat
antivir
respons
rigilik
receptor
rlr
pathway
classic
studi
role
detect
viral
ribonucl
acid
involv
retino
acidinduc
gene
rigi
melanoma
differentiationassoci
protein
laboratori
genet
physiolog
cytosol
sensor
infect
ubiquit
express
abl
sens
specif
viral
rna
moieti
short
uncap
triphosphoryl
singlestrand
ss
rna
short
doublestrand
ds
rna
uarich
region
viral
rna
long
dsrna
upon
bind
vrna
rigi
activ
transloc
surfac
mitochondria
interact
adaptor
protein
mitochondri
antiviralsignal
protein
mav
via
respect
caspas
activ
recruit
domain
card
figur
upper
panel
trigger
mav
oligomer
format
prionlik
structur
requir
transduc
signal
downstream
effector
protein
signal
platform
often
call
mav
signalosom
believ
bring
togeth
mitochondri
surfac
upstream
prr
downstream
regulatori
subunit
nemo
protein
kinas
ikbk
also
known
activ
signalosom
orchestr
phosphoryl
transcript
factor
result
nuclear
transloc
induct
type
ifn
remark
activ
mav
regulom
tightli
regul
morphodynam
mitochondria
well
contact
er
see
sum
mitochondria
outer
membran
scaffold
rlr
signal
thu
play
essenti
role
initi
propag
amplif
innat
immun
rna
virus
date
sever
line
evid
suggest
denv
preferenti
directli
sens
rlr
pathway
earli
studi
use
rigi
dominantneg
mutant
show
rigi
requir
trigger
antivir
immun
denv
lung
cancer
cell
observ
recapitul
variou
cell
type
hepatocarcinoma
cell
endotheli
cell
primari
monocyt
experiment
set
combin
affin
purif
nextgener
sequenc
chazal
colleagu
recent
show
rigi
abl
recogn
ppp
uncap
denv
vrna
suggest
detect
denv
nucleic
acid
occur
end
matur
cap
complet
vrna
afterward
hidden
prr
stark
contrast
put
role
detect
denv
nucleic
acid
remain
unclear
sever
group
shown
silenc
interf
result
increas
viral
suscept
alter
innat
immun
respons
clear
mechan
direct
vrna
sens
emerg
despit
bodi
evid
might
due
fact
studi
address
role
earli
detect
vrna
strikingli
case
wnv
rigi
nonredund
role
variou
stage
infect
vitro
vivo
inde
shown
signal
reli
presenc
wnv
rna
pamp
process
cellular
factor
becom
immunostimulatori
virion
rna
initi
uncoat
upon
viral
entri
overal
studi
support
view
rigi
major
player
earli
detect
denv
rna
initi
immun
respons
highlight
addit
work
requir
defin
role
denv
infect
tolllik
receptor
tlr
constitut
anoth
import
famili
prr
locat
plasma
membran
within
late
endosom
sens
varieti
pamp
bacteri
lipopolysaccharid
dsdna
ssrna
dsrna
denv
infect
recogn
vrna
stimul
overexpress
dampen
denv
replic
cellulo
tlr
rlr
pathway
converg
mav
stimul
type
ifn
product
remain
unknown
whether
denv
stimul
vivo
studi
rhesu
macaqu
show
combin
agonistmedi
stimul
follow
denv
infect
result
decreas
viral
replic
enhanc
proinflammatori
respons
highlight
antivir
potenti
pathway
denv
vivo
converg
downstream
effector
molecul
rlr
pathway
axi
foreign
dnasens
pathway
reli
variou
intracellular
dna
sensor
cyclic
gmpamp
synthas
cga
detect
dsdna
danger
signal
self
pathogen
upon
bind
cga
produc
second
messeng
cyclic
gmpamp
cgamp
turn
activ
stimul
interferon
gene
sting
engag
stingcga
pathway
lead
stimul
ultim
product
type
ifn
sinc
discoveri
pathway
centr
mani
research
interest
field
cancer
autoimmun
inflamm
senesc
cell
death
viral
infect
among
other
interestingli
sens
dna
cgasst
pathway
report
essenti
optim
innat
immun
respons
rna
virus
surprisingli
sever
virus
influenza
viru
hepat
c
viru
coronaviru
develop
target
evas
mechan
interfer
pathway
involv
cga
sting
innat
immun
respons
denv
becom
evid
last
year
sever
report
show
denv
actual
modul
pathway
see
remain
unclear
dnabind
protein
like
cga
detect
viral
rna
recent
suggest
sens
denv
infect
rather
occur
indirectli
inde
virusinduc
mitochondri
stress
lead
leakag
mitochondri
dna
mtdna
cytosol
subsequ
sens
cga
turn
activ
type
ifn
respons
recent
shown
follow
inflammasom
activ
secret
interleukin
il
induc
mtdna
releas
lead
stimul
cga
pathway
ifn
product
consid
denv
infect
trigger
activ
inflammasom
human
platelet
macrophag
plausibl
indirectli
contribut
mtdnadepend
induct
earli
innat
immun
lastli
emerg
concept
cross
talk
rigimav
cgasst
pathway
sure
interest
understand
denv
biolog
inde
accumul
literatur
show
rlr
pathway
abl
potenti
cgasst
pathway
vice
versa
rna
viru
infect
seem
occur
physic
connect
rig
mav
sting
viral
infect
coactiv
pathway
transcript
feedback
loop
flavivir
infect
studi
shown
sting
potenti
rlr
signal
via
assembl
rigimavsst
complex
follow
jev
nucleic
acid
recognit
addit
anoth
studi
mice
shown
cga
requir
optim
rlrdepend
ifn
respons
wnv
inde
cga
mice
higher
viral
load
lower
isg
express
result
higher
mortal
compar
wildtyp
control
futur
studi
requir
assess
role
cross
talk
rigimav
cgasst
denv
infect
gener
requir
investig
exact
natur
role
distribut
immunomodulatori
molecul
signal
adaptor
produc
express
result
pathogenesi
denv
infect
ultim
provid
mechanist
insight
exact
contribut
cgasst
pathway
denv
infect
denv
rna
synthesi
cap
believ
occur
within
vp
sinc
viral
replic
dsrna
intermedi
local
within
erderiv
ultrastructur
shown
imag
studi
use
immunogold
label
electron
microscopi
confin
environ
probabl
import
concentr
metabolit
protein
requir
replic
also
exclud
potenti
inhibitori
host
factor
consid
tempt
specul
neosynthes
uncap
denv
rna
hide
rigi
vp
although
model
remain
experiment
valid
replic
denv
rna
molecul
possess
sever
intrins
featur
allow
evas
detect
innat
immun
system
sens
interfer
strategi
reli
two
specif
modif
vrna
omethyl
partial
degrad
host
nucleas
figur
bottom
left
panel
addit
rna
polymeras
function
denv
methyltransferas
mtase
activ
gener
cap
also
methyl
oh
posit
first
nucleotid
form
type
cap
structur
omethyl
vrna
mimic
cellular
mrna
thu
evad
host
immun
system
figur
surprisingli
mechan
necessarili
strictli
depend
cap
vrna
sinc
intern
omethyl
occur
vrna
lack
cap
structur
infect
denv
flaviviru
wnv
omethyl
shown
import
avoid
coronaviru
infect
recognit
mous
human
cell
inde
mutant
defici
mtase
activ
mutat
lead
attenu
viral
spread
ifncompet
cell
consist
later
shown
replic
omtas
mutant
attenu
earli
stage
life
cycl
ie
first
h
infect
shown
transcriptom
kinet
analysi
result
increas
isg
transcript
earli
time
point
postinfect
enrich
prr
gene
rigi
altogeth
studi
strongli
support
denv
omethyl
aim
hide
viral
nucleic
acid
earli
recognit
rlr
importantli
omtas
mutant
strain
identifi
vaccin
candid
sinc
immun
confer
protect
subsequ
denv
infect
mice
rhesu
macaqu
howev
propos
exacerb
immun
respons
might
due
rather
omethylationmedi
evas
antivir
action
specif
isg
enact
downstream
rlr
ifn
signal
see
anoth
vrnarel
evas
mechan
reli
partial
degrad
vrna
host
factor
result
gener
subgenom
flaviviru
rna
sfrna
small
noncod
rna
figur
sfrna
produc
byproduct
incomplet
degrad
flavivir
rna
due
uniqu
secondari
structur
utr
caus
exoribonucleas
stall
cut
vrna
prematur
produc
test
flavivirus
accumul
biolog
activ
sfrna
contribut
virusinduc
cytopath
effect
hijack
mrna
process
machineri
promot
optim
viral
replic
relev
help
viru
circumv
antivir
signal
inde
case
denv
one
studi
show
denv
sfrna
abl
inhibit
deubiquityl
prevent
polyubiquityl
rigi
dimer
via
card
domain
subsequ
interact
downstream
adaptor
protein
mav
result
hinder
interferon
signal
whole
vrna
methyl
degrad
sfrna
consist
two
evolutionarili
conserv
flavivir
strategi
counteract
innat
antivir
immun
addit
interf
rlr
sens
vrna
denv
develop
evas
strategi
inhibit
signal
cascad
follow
rlr
activ
sever
denv
protein
modul
pathway
upstream
downstream
mav
notabl
denv
conserv
phosphomimet
rxep
motif
abl
prevent
rigi
transloc
mitochondria
sequest
figur
requir
effici
associ
subsequ
recruit
mitochondria
interact
mav
importantli
virus
express
mutat
unabl
associ
elicit
stronger
immun
respons
replic
less
effici
immunecompet
cell
moreov
denv
abl
bind
mav
card
domain
effect
prevent
rigimav
interact
unknown
mechan
order
sustain
maintain
immun
synaps
mav
need
physic
access
proper
posit
surfac
mitochondria
otherwis
antivir
signal
respons
may
optim
target
aspect
rlrdepend
innat
immun
signal
denv
also
abl
chang
architectur
mitochondria
term
morphodynam
contact
endoplasm
reticulum
figur
first
mitochondria
show
elong
morpholog
denvinfect
cell
make
contact
denv
convolut
membran
interestingli
mitochondri
morphodynam
report
modul
antivir
signal
morpholog
mitochondria
reli
equilibrium
fusion
fission
regul
dynaminlik
gtpase
briefli
key
player
mitofusin
optic
atrophi
mediat
fusion
lead
elong
dynaminrel
protein
mediat
mitochondri
fission
denvinduc
mitochondria
elong
attribut
sinc
overexpress
alon
recapitul
phenotyp
furthermor
inhibit
phosphorylationdepend
activ
observ
infect
cell
thu
favour
mitochondri
elong
fission
second
denv
infect
result
drastic
disrupt
contact
mitochondria
er
ermc
interestingli
residu
mitochondriaassoci
membran
mam
appear
connect
cm
suggest
biogenesi
denv
rf
substructur
respons
ermc
disrupt
notabl
mam
import
normal
rlr
signal
sinc
favour
tether
mav
requir
optim
antivir
signal
suggest
alter
reticulomitochondri
interfac
denv
would
contribut
dampen
rlr
signal
strong
support
upon
enforc
mitochondria
elong
via
express
knockdown
denvinfect
cell
rigi
bare
recruit
mam
correl
dampen
type
iii
ifn
mrna
transcript
increas
viral
replic
highlight
function
interplay
mitochondria
morphodynam
contact
er
anoth
studi
yu
colleagu
show
denv
proteas
cleav
interestingli
overexpressionmedi
hyperfus
mitochondria
perinuclear
region
result
decreas
viral
replic
moreov
independ
express
knockdown
led
differ
phenotyp
viral
replic
induct
cell
death
illustr
diverg
role
mitofusin
despit
similar
consist
differ
assum
function
dock
fusion
mitochondria
stabil
interact
mitochondria
furthermor
local
mam
erresid
protein
tether
mitochondria
er
homodimer
heterotyp
interact
suggest
denv
might
alter
ermc
directli
target
proteas
activ
without
necessarili
impact
mitochondria
fusion
elong
overal
studi
support
model
antivir
signal
depend
variou
spatiotempor
event
alter
mitochondri
morpholog
cytosol
interfac
regul
mav
signalosom
function
concept
viral
subvers
mitochondri
morphodynam
uniqu
denv
sinc
relat
strategi
observ
virus
hepat
b
viru
hepat
c
viru
sever
acut
respiratori
syndromerel
coronaviru
sarscov
alphaherpesviru
addit
er
mitochondria
denv
impair
morpholog
anoth
membran
organel
function
link
mavsrel
signal
inde
denv
well
wnv
zikv
induc
loss
cellular
peroxisom
contain
mav
surfac
constitut
transduct
platform
innat
signal
notabl
express
knockdown
peroxin
essenti
peroxisom
biogenesi
led
signific
decreas
type
iii
ifn
gene
transcript
follow
activ
rlr
signal
synthet
dsrna
highlight
import
peroxisom
integr
innat
immun
signal
benefit
denv
deplet
upon
infect
overal
chang
cellular
endomembran
morpholog
believ
creat
cytoplasm
microenviron
viral
protein
abl
engag
cellular
host
factor
crucial
mount
adequ
antivir
respons
final
downstream
mav
denv
also
abl
evad
rlr
signal
interf
activ
effector
protein
figur
inde
abl
block
phosphoryl
interf
serin
kinas
activ
ikbk
lead
suboptim
type
ifn
respons
evas
strategi
consist
idea
denv
physic
target
mav
signalosom
entireti
bring
togeth
upstream
downstream
factor
cytosol
side
mitochondria
interestingli
sever
denv
protein
involv
coopt
name
interact
partli
local
within
cm
furthermor
cm
make
elong
mitochondria
strong
evid
origin
mam
import
compart
mavsdepend
signal
altogeth
support
model
cm
constitut
hijack
unit
target
whole
mav
signalosom
multipl
level
rather
directli
regul
vrna
replic
viral
substructur
would
instead
shutoff
potenti
antivir
respons
infect
includ
earli
innat
immun
henc
creat
cytoplasm
environ
favour
viral
replic
close
spatial
relationship
cm
mitochondria
would
help
trap
host
target
insid
cm
concentr
near
viral
protein
order
effici
downregul
mav
signalosom
maxim
viral
evas
nevertheless
model
requir
experiment
challeng
denv
also
capac
directli
interfer
ifn
induct
trigger
activ
cgasst
pathway
result
releas
mtdna
cytoplasm
follow
denv
infect
figur
inde
denv
mark
cga
lysosom
degrad
denv
proteas
cleav
sting
suppress
type
ifn
induct
interestingli
denv
process
either
mous
nonhuman
primat
sting
ortholog
suggest
pathogen
evolv
toward
optim
pathogen
natur
host
recent
report
mitochondri
fission
result
mitochondri
stress
releas
mtdna
cytosol
consid
interest
investig
futur
whether
denvinduc
mitochondri
elong
inhibit
actual
dampen
rigi
signal
also
activ
stingcga
pathway
andor
cross
talk
rlr
signal
line
idea
sting
resid
protein
mam
alter
structur
denv
infect
might
contribut
target
sting
cm
degrad
spatiotempor
sequestr
addit
primari
viru
sens
pathway
denv
also
abl
target
sever
compon
downstream
interferoninduc
jakstat
signal
cascad
normal
lead
sustain
express
variou
isg
follow
secret
figur
earli
vitro
assay
demonstr
denv
abl
prevent
activ
mechan
conserv
wnv
yfv
yet
elucid
howev
ration
inhibit
like
occur
either
prevent
activ
dephosphoryl
degrad
activ
matter
anoth
stat
protein
denv
abl
bind
promot
ubiquitin
ligas
degrad
result
drastic
decreas
basal
express
level
henc
hinder
jakstat
signal
interestingli
evas
strategi
also
conserv
flavivirus
zikv
inde
zikv
abl
bind
promot
proteasom
degrad
manner
addit
role
degrad
denv
protein
also
abl
interfer
isg
express
first
denv
zikv
select
inhibit
isg
express
bind
antagon
transcript
factor
second
denv
hijack
core
compon
spliceosom
machineri
name
result
alter
isoform
abund
stoichiometri
mani
antivir
factor
rigi
henc
contribut
environ
favour
viral
replic
posttranscript
level
sfrna
shown
interfer
translat
isg
inde
denv
sfrna
associ
host
rnabind
protein
result
unabl
stimul
effici
translat
mani
isg
pkr
instanc
consist
sfrna
bind
host
factor
protect
denv
replic
treatment
interestingli
omethyl
mechan
describ
way
downregul
prr
earli
ifn
respons
also
abl
interfer
function
specif
isg
inde
replic
omtas
mutant
significantli
sensit
treatment
wt
viru
demonstr
modif
may
contribut
immun
evas
downstream
prr
signal
specif
denv
also
wnv
poxviru
coronaviru
jev
omethyl
vrna
cap
enabl
viral
nucleic
acid
mark
selfrna
evad
antivir
function
ifninduc
protein
tetratricopeptid
repeat
ifit
protein
notabl
shown
associ
nonmethyl
rna
higher
affin
ifit
propos
translat
initi
factor
compet
cap
bind
henc
sens
viru
infect
bind
foreign
rna
lack
omethyl
inhibit
translat
viral
rna
via
displac
consist
overexpress
cell
significantli
decreas
replic
contrast
ifit
case
wnv
pathogenesi
mtase
mutant
greatli
attenu
wt
mice
interestingli
intracrani
infect
knockout
mice
mtase
mutant
wnv
restor
lethal
highlight
critic
role
ifit
sens
omethylfre
vrna
vivo
consid
genet
biolog
proxim
wnv
tantal
specul
denv
rna
abl
evad
ifit
antivir
activ
vivo
mimick
cellular
mrna
addit
omethyl
one
common
posttranscript
modif
rna
allow
vrna
hide
plain
sight
among
host
mrna
explain
denv
sfrna
target
innat
immun
signal
human
cell
multipl
level
ie
rigi
activ
isg
express
signific
interest
sever
recent
studi
highlight
import
role
sfrna
dissemin
denv
among
infect
insect
fact
denv
yfv
subgenom
rna
abl
interfer
aed
mosquito
innat
system
well
target
toll
receptor
rna
interfer
rnai
pathway
favour
optim
replic
mosquito
viral
doublestrand
rna
process
small
sirna
rnase
iii
dicer
process
viral
sirna
vsirna
abl
target
viral
rna
silenc
show
sfrna
play
two
distinct
role
albeit
use
cellular
factor
evas
innat
immun
respons
mammalian
host
arthropod
vector
concept
differ
role
host
factor
mammalian
host
arthropod
vector
like
explor
depth
futur
consid
recent
system
biolog
studi
identifi
share
pathway
interact
denvhuman
denvmosquito
interactom
context
innat
immun
evas
viral
pathogenesi
multipl
tetraval
vaccin
candid
develop
includ
liveattenu
vaccin
whole
viru
inactiv
vaccin
proteinbas
vaccin
chimer
vaccin
mrnabas
synthet
viruslik
particl
vaccin
among
vaccin
dengvaxia
also
call
cydtdv
develop
sanofi
pasteur
one
licens
use
dengueendem
countri
asia
latin
america
oceania
well
europ
cydtdv
tetraval
dengu
chimer
liveattenu
vaccin
base
yfv
strain
backbon
vaccin
typic
indic
individu
age
year
live
endem
countri
henc
access
popul
risk
develop
sever
denguerel
symptom
unfortun
vaccin
confer
less
protect
serotyp
serotyp
importantli
cydtdv
efficaci
higher
pool
estim
seroposit
individu
extrem
low
seroneg
children
risk
sever
complic
due
vaccin
probabl
consequ
global
vaccin
campaign
school
philippin
result
death
mani
children
suspens
program
depart
health
late
prevaccin
screen
previou
exposur
recommend
prior
vaccin
lastli
studi
show
cydtdvelicit
memori
respons
decreas
time
measur
low
antibodi
titr
blood
sampl
year
follow
initi
threedos
vaccin
regimen
suggest
booster
dose
might
need
sustain
longterm
immunolog
protect
develop
new
dengu
vaccin
safe
highli
efficaci
serotyp
face
mani
challeng
includ
involv
interplay
viru
immun
system
semin
studi
albert
sabin
date
wwii
era
demonstr
volunt
expos
denv
show
longliv
homotyp
immun
shortliv
crossprotect
virus
differ
serotyp
howev
mechan
behind
observ
still
fulli
understood
prospect
studi
popul
level
show
conclus
gener
inform
ration
vaccin
design
major
denv
infect
go
unnot
infect
individu
progress
along
diseas
spectrum
develop
dengu
hemorrhag
fever
dengu
shock
although
consensu
exist
pathophysiolog
behind
progress
like
due
hostspecif
factor
relat
presenc
preexist
immun
antibodydepend
enhanc
ade
immunemedi
cytokin
storm
relat
antigen
sin
phenomenon
occur
even
past
peak
viremia
symptomat
individu
inde
second
heterolog
denv
infect
expect
elicit
strong
memori
recal
denvspecif
b
cell
produc
enhanc
level
cytokin
neutral
antibodi
howev
adapt
immun
respons
might
lead
control
viremia
rather
quit
opposit
result
antibodydepend
enhanc
infect
viru
opson
increas
replic
mast
cell
activ
vascular
permeabl
cellular
cytotox
cytokin
storm
mind
effect
antivir
therapi
would
need
taken
prophylact
treatment
would
like
highli
expens
given
number
individu
live
endem
area
thu
way
erad
dengu
worldwid
would
develop
safe
effect
panserotyp
vaccin
confer
longterm
steril
immun
summari
cydtdv
constitut
safe
efficaci
tool
therapeut
arsen
denv
properli
administ
plagu
shortcom
controversi
complet
meet
need
effect
dengu
vaccin
especi
seroneg
individu
thu
mani
challeng
remain
address
develop
holi
grail
denv
vaccin
better
understand
hostpathogen
interact
warrant
set
new
vaccin
strategi
relev
anim
model
follow
section
discuss
three
exampl
illustr
innat
immun
research
inform
vaccin
design
live
attenu
vaccin
candid
engin
delet
nucleotid
utr
vrna
use
revers
genet
subsequ
creat
modifi
dengu
virus
four
serotyp
proofofconcept
studi
show
despit
attenu
highli
immunogen
human
rhesu
monkey
test
serotyp
confer
protect
upon
homolog
rechalleng
addit
appear
less
virul
mosquito
limit
risk
transmiss
vaccin
human
aed
vector
long
molecular
mechan
confer
attenu
vaccin
candid
larg
unknown
howev
shown
cell
accumul
less
sfrna
result
increas
sensit
type
ifn
studi
requir
assess
evas
mechan
play
attenu
fulli
understand
strain
abl
creat
balanc
environ
favour
antigen
present
cytokin
product
howev
given
report
role
sfrna
ifn
product
respons
see
like
attenu
result
increas
innat
immun
respons
explain
omethyl
modif
allow
vrna
mimic
cellular
mrna
evad
host
innat
immun
system
use
revers
genet
colleagu
gener
denv
clone
serotyp
harbour
singl
point
mutat
conserv
kdke
motif
methyltransferas
catalyt
site
mutant
impair
omethyl
still
abl
perform
cap
importantli
suscept
ifn
treatment
human
overexpress
wildtyp
denv
consist
idea
impair
ifit
inhibit
importantli
treatment
mice
compet
tcell
respons
virus
alon
serotyp
combin
confer
protect
subsequ
infect
lethal
mouseadapt
denv
strain
remark
singl
low
dose
mutant
monkey
enough
complet
seroconvers
protect
approach
also
appli
develop
jev
vaccin
candid
mutant
jev
attenu
sensit
type
ifn
treatment
well
singl
dose
live
attenu
vaccin
suffici
elicit
strong
humor
respons
confer
protect
surviv
follow
heterolog
rechalleng
balbc
mice
ongo
studi
tri
implement
vaccin
ration
design
toward
develop
tetraval
nonchimer
vaccin
therapeut
relev
vaccin
develop
studi
usual
reli
larg
anim
model
nonclin
preclin
studi
use
small
anim
model
mice
usual
requir
genet
modif
dampen
immun
system
order
increas
viral
permiss
thu
reflect
realiti
infect
natur
host
intact
immun
respons
case
vivo
denv
studi
classic
involv
immunodefici
mous
strain
express
receptor
mice
highli
suscept
denv
infect
gener
die
within
two
week
inject
follow
advanc
knowledg
hostpathogen
interact
advent
novel
technolog
eg
gene
edit
paradigm
shift
anticip
exampl
use
gene
knockin
approach
mouseadapt
viru
strain
gorman
colleagu
recent
develop
immunocompet
transgen
mous
model
zivk
infect
replac
mous
human
genet
engin
conceptu
made
possibl
thank
previou
studi
show
zikv
induc
degrad
human
mous
ortholog
interest
see
use
human
immunocompet
mous
model
expand
denv
studi
definit
open
mani
futur
research
opportun
denv
research
like
remain
challeng
excit
field
time
come
recent
year
denv
infect
taken
front
seat
realm
global
health
concern
spread
outsid
western
pacif
region
threaten
billion
individu
effect
antivir
therapi
prophylact
vaccin
denv
expect
caus
diseas
inflict
harm
amount
million
dali
extens
discuss
review
denv
well
equip
evad
innat
antivir
immun
system
variou
antagon
function
viral
ns
protein
rna
abl
hide
plain
sight
due
omethyl
viral
genom
disrupt
mav
signalosom
activ
ifn
signal
acknowledg
despit
simpl
viral
genom
organ
denv
pathogenesi
reli
complex
network
hostpathogen
interact
conceiv
better
understand
complex
contribut
solv
puzzl
dengu
control
andor
erad
inde
interplay
denv
immun
system
lead
ration
vaccin
design
provid
attract
target
antigen
adjuv
develop
fill
gap
knowledg
regard
innat
immun
system
har
support
longlast
protect
immun
respons
